West Pharmaceutical(WST) - 2025 Q4 - Annual Results
Exhibit 99.1 West Reports Fourth-Quarter and Full-Year 2025 Results – Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – Exton, PA, February 12, 2026 – West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year 2025 Summary (comparisons to prior-year p ...